Australia markets close in 3 hours 11 minutes

EDIT Jan 2026 5.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.1000-0.5000 (-19.23%)
As of 02:46PM EDT. Market open.
Full screen
Previous close2.6000
Open2.5100
Bid2.0000
Ask2.2000
Strike5.00
Expiry date2026-01-16
Day's range2.0500 - 2.5100
Contract rangeN/A
Volume32
Open interest236
  • Thomson Reuters StreetEvents

    Q1 2024 Editas Medicine Inc Earnings Call

    Q1 2024 Editas Medicine Inc Earnings Call

  • Zacks

    Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

    Editas (EDIT) delivered earnings and revenue surprises of -20.63% and 90.26%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Editas Medicine Announces First Quarter 2024 Results and Business Updates

    Completed adult cohort enrollment and enrolled multiple patients in the adolescent cohort of the Phase 1/2/3 RUBY clinical trial of reni-cel for severe sickle cell disease On track to present additional clinical data from the RUBY trial and the EdiTHAL trial of reni-cel for transfusion-dependent beta-thalassemia in mid-2024 and additional updates by year-end 2024 Presenting pre-clinical data at ASGCT on in vivo capabilities to support development of transformative in vivo gene editing medicines